selected publications
-
Monitoring and Management of the Patient with Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Current Perspectives.
Journal of inflammation research.
2022
Review
GET IT
Times cited: 15 -
Autoantibodies in Patients With Immune-Related Adverse Events From Checkpoint Inhibitors: A Systematic Literature Review.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
2022
Academic Article
GET IT
Times cited: 20 -
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
Journal for immunotherapy of cancer.
2022
Academic Article
GET IT
Times cited: 17 -
Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series.
2021
GET IT
Times cited: 21 - Pembrolizumab-Induced Phenotypic Switch in Psoriatic Arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2021 Academic Article GET IT
-
Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study.
Journal for immunotherapy of cancer.
2021
Academic Article
GET IT
Times cited: 3 -
Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry.
ACR open rheumatology.
2020
Academic Article
GET IT
Times cited: 6 -
Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 2 -
Autoimmune complications of immunotherapy: pathophysiology and management.
BMJ (Clinical research ed.).
2020
Academic Article
GET IT
Times cited: 56 -
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
The oncologist.
2019
Review
GET IT
Times cited: 31 -
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor.
Annals of the rheumatic diseases.
2018
Letter
GET IT
Times cited: 8